Bicara Therapeutics (NasdaqGM:BCAX) FY Conference Transcript

Bicara Therapeutics (NasdaqGM:BCAX) FY Conference March 10, 2026 11:30 AM ET Company ParticipantsRyan Cohlhepp - President and COOModeratorOne, Carter Gould, Senior Biotech Analyst at Barclays. Happy to have Bicara Therapeutics with us for our next session. We have Ryan Cohlhepp, President and Chief Operating Officer. Ryan, maybe for those less familiar with the story, could you just give us an overview of Bicara and progress that you've made in upcoming milestones?Ryan CohlheppYeah, great. Now, thank you f ...